Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes

Abstract Purpose Myelodysplastic syndromes/neoplasms (MDS) represent a heterogeneous group of clonal hematopoietic disorders with variable prognosis. While several risk models exist, the prognostic role of immune-related biomarkers remains unclear. This study aimed to determine whether the lymphocyt...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, Chia-Lang Hsu, Chi-Yuan Yao, Feng-Ming Tien, Min-Yen Lo, Yu-Sung Chang, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Mei-Hsuan Tseng, Yen-Ling Peng, Ming Yao, Bor-Sheng Ko, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer Nature 2025-12-01
coleção:	Blood Research
Assuntos:	Myelodysplastic syndromes/neoplasms Prognosis Risk stratification Lymphocyte Monocyte
Acesso em linha:	https://doi.org/10.1007/s44313-025-00115-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!